Sort
40,608 grants matching “prostate cancer”
Mechanisms and Therapies of B7x and B7-H3 in T1D
$375,750Xingxing Zang · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · DK
Mechanisms and Therapies of B7x and B7-H3 in T1D
$375,750Xingxing Zang · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · DK
Mechanisms and Therapies of B7x and B7-H3 in T1D
$375,750Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2019 · DK
Mechanisms and therapies of B7x and B7-H3 in T1D
$375,750Xingxing Zang · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · DK
WNT5a/ROR2-Mediated Hippo Pathway Activation in Prostate Cancer
$375,734Steven P. Balk · Beth Israel Deaconess Medical Center · R01 · FY2024 · CA
USING METABOLIC PATHWAYS TO IMPROVE DIAGNOSIS AND RISK STRATIFICATION OF PROSTATE CANCER
$375,725University Of Maryland, Baltimore · · FY2016 · Department of Defense
Early Cancer Detection & Prognosis through Glycomics
$375,682Milos V Novotny · Trustees Of Indiana University · U01 · FY2009 · CA
The Notch signaling in prostate homeostasis and carcinogenesis
$375,669Li Xin · University Of Washington · R01 · FY2019 · CA
ONCOGENIC ROLE OF JUN KINASE IN HUMAN PROSTATE CANCER
$375,644Sidney Kimmel Cancer Center · R01 · FY2002 · CA
ONCOGENIC ROLE OF JUN KINASE IN HUMAN PROSTATE CANCER
$375,644Sidney Kimmel Cancer Center · R01 · FY2001 · CA
ONCOGENIC ROLE OF JUN KINASE IN HUMAN PROSTATE CANCER
$375,644Sidney Kimmel Cancer Center · R01 · FY2000 · CA
ONCOGENIC ROLE OF JUN KINASE IN HUMAN PROSTATE CANCER
$375,644Sidney Kimmel Cancer Center · R01 · FY2003 · CA
Quantitative Analysis of Epidermal Growth Factor Receptor Signaling Networks
$375,642Forest M White · Massachusetts Institute Of Technology · R01 · FY2010 · CA
AKR1C3 Inhibitors as Chemotherapeutic Potentiators
$375,590Paul Trippier · University Of Nebraska Medical Center · R01 · FY2023 · CA
Advanced development and validation of genome-scale molecular diagnostics for microsatelliteinstability using targeted molecular counting methods
$375,579Stephen J Salipante · University Of Washington · R33 · FY2019 · CA
AKR1C3 Inhibitors as Chemotherapeutic Potentiators
$375,548Paul Trippier · University Of Nebraska Medical Center · R01 · FY2022 · CA
Time-resolved FRET-based allostery sensors for any protein kinase drug target
$375,535Nicholas Mark Levinson · University Of Minnesota · R33 · FY2020 · CA
Developmental Funds
$375,528Suresh S Ramalingam · Emory University · P30 · FY2024 · CA
Selenium molecular signaling in human prostate cancer
$375,522Roswell Park Cancer Institute Corp · R01 · FY2005 · CA
Inside-Out Nonlinear Gradients to Improve Diffusion MRI
$375,493Gigi Galiana · Yale University · R01 · FY2022 · CA
Inside-Out Nonlinear Gradients to Improve Diffusion MRI
$375,493Gigi Galiana · Yale University · R01 · FY2023 · CA
Role and targeting of PRMT5 in prostate cancer
$375,488Chang-Deng Hu · Purdue University · R01 · FY2021 · CA
Project 1 High-order assembly of MegaTrans complexes for hormone-independent enhancer activation
$375,474Zhijie "jason" Liu · University Of Texas Hlth Science Center · U54 · FY2020 · CA
The role and mechanism of RNA m6A modification in the pathogenesis and drug-resistance of prostate cancer
$375,411Jihoon Lee · University Of Texas Hlth Science Center · R01 · FY2025 · CA
A Limited-angle Intra-fractional Verification (LIVE) System for SBRT Treatments
$375,348Lei Ren · Duke University · R01 · FY2015 · CA